Vaxcyte, Inc.
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in …
Mergers & Acquisitions Beta
M&A Details · Industry · Urgent
M&A Deals · Breakdown
Vaxcyte, Inc. has no acquisition track records yet.
M&A Deals · History
Vaxcyte, Inc. has no acquisition track records yet.
M&A Deals · Within Industry
No current deals within Biotechnology Industry.
M&A Deals · Latest
Act, dont react; Track the most urgent M&A deals across all industries